|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07D 237/32 | (2006.01) |
| (11) | Patento numeris | 2824098 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 14181346.9 |
| Europos patento paraiškos padavimo data | 2007-10-15 | |
| (97) | Europos patento paraiškos paskelbimo data | 2015-01-14 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2016-06-22 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (30) | Numeris | Data | Šalis |
| 829694 P | 2006-10-17 | US |
| (72) |
Menear, Keith, GB
Ottridge, Anthony, GB
Londesbrough, Derek, GB
Hallett, Michael, GB
Mullholland, Keith, GB
Pittam, John, GB
Laffan, David, GB
Ashworth, Ian, GB
Jones, Martin, GB
Cheryman, Janette, GB
|
| (73) |
Kudos Pharmaceuticals Limited,
1 Francis Crick Avenue, Cambridge Biomedical Campus
Cambridge CB2 0AA,
GB
|
| (54) | Method for the preparation of 4-[3-(4-cyclopropanecarbonyl- piperazine-1-carbonyl)-4-fluoro-benzyl]-2H-phthalazin-1-one |
| Method for the preparation of 4-[3-(4-cyclopropanecarbonyl- piperazine-1-carbonyl)-4-fluoro-benzyl]-2H-phthalazin-1-one |